New Patient Appointment or 214-645-8300

MedBlog

All Cancer

Cancer

Closer to a cure

A new clinical trial at UT Southwestern aims to offer new hope for patients with multiple myeloma.

Cancer

The Fight Continues

When 72-year-old Larry Carlson was diagnosed with stage 4 kidney cancer, he simply didn’t believe the news. Initially, Mr. Carlson was in denial about his cancer, but once he accepted the diagnosis, he decided that giving up wasn’t going to be a part of his plan.

Cancer

Prostate cancer genomic testing is flawed: Three reasons why

Men with prostate cancer want to know the future: Will my cancer get worse? Do I need surgery? Genomic testing can help us make educated recommendations, but it’s far from perfect. Claus Roehrborn, M.D., explains why genomic testing isn’t a “crystal ball” for predicting prostate cancer risk.

Cancer

Ovarian cancer: A step closer to demystifying early detection and prevention

Confirmed: Ovarian cancer begins in the fallopian tubes, not the ovaries. Discover how new research might be the key to overcoming barriers to early detection and prevention.

Cancer

Beat AML: Promising outcomes for seniors with acute myeloid leukemia

Treatment options for acute myeloid leukemia (AML) in seniors have remained stagnant for 40 years. We are participating in Beat AML, a research study focused on swift phenotyping and tailored therapies, with the ultimate goal of improving outcomes in this disease that otherwise becomes increasingly difficult to treat as patients age.

Cancer

Perspectives 75: Misti

After finding a lump in her breast, Misti was diagnosed with stage 2 invasive ductal carcinoma with lobular features.

Cancer

CAR-T Therapy Offers Patients Promise for a Cure

Multiple myeloma is the second fastest growing type of cancer for men and the third fastest for women.

Cancer

Patient benefits from neoadjuvant breast cancer clinical trials

Breast cancer clinical trials are not experiments. Rather, they are options for women with breast cancer to receive the gold standard of cancer care paired with advanced therapies that can greatly improve their outcomes.

Cancer

Dr. Brugarolas’ perspective: Treating cancer with a one-two punch